Promoters hold 69.8% of Orchid Pharma Limited (ORCHPHARMA). FIIs hold 0.8%, mutual funds 19.9% and other DIIs 0.8%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.8% | 69.8% | 69.8% | 69.8% | 69.8% | 69.8% | 69.8% | 69.8% | 69.8% | 69.8% | 69.8% | 72.4% |
| FII | 0.8% | 0.9% | 1.2% | 1.6% | 1.4% | 2.7% | 2.5% | 1.9% | 1.4% | 2.0% | 4.1% | 8.1% |
| MF | 19.9% | 19.4% | 18.0% | 18.0% | 18.6% | 18.8% | 17.5% | 16.8% | 16.9% | 15.2% | 10.4% | 9.8% |
| Other DII | 0.8% | 0.8% | 1.4% | 1.0% | 0.8% | 1.3% | 1.5% | 1.5% | 2.0% | 2.5% | 4.1% | 2.7% |
| Retail & others | 8.6% | 9.1% | 9.6% | 9.6% | 9.3% | 7.4% | 8.6% | 9.9% | 9.8% | 10.5% | 11.5% | 7.1% |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
No PIT or SAST disclosures on record for this stock in the last 12 months.
That is the usual state — promoters, directors and holders above 5% file only when they trade or pledge; a new filing appears here within a day of reaching the exchange.
In Jun 26, FII holding fell −0.1pp and mutual funds +0.5pp, while retail trimmed −0.4pp. Rising institutional ownership is often read as “smart money” accumulation — though it’s never a guarantee.
Quarterly shareholding patternas of Jun 26
